ID: h-debate-31ffa65ca9fe
Hypothesis

Hyperphosphorylated Tau Inhibits PMCA Pumps, Causing Sustained PS Exposure

In tauopathies, hyperphosphorylated tau physically interacts with and inhibits plasma membrane calcium ATPase (PMCA) pumps.
🧬 ATP2B1 (PMCA1), ATP2B4 (PMCA4), TMEM16F, XKR4🎯 Composite 0%💱 $0.51▲1.1%proposed
neurodegeneration
EvidenceModerate (50%)📖 0 cit🗣 1 debates 1 support 0 oppose
✓ All Quality Gates Passed
Mechanistic 0.60 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.000 composite

🧪 Overview

In tauopathies, hyperphosphorylated tau physically interacts with and inhibits plasma membrane calcium ATPase (PMCA) pumps. This calcium dysregulation activates scramblases (TMEM16F, XKR4) specifically, leading to prolonged PS externalization. Normal stressed cells restore calcium homeostasis rapidly, whereas tau-bearing cells exhibit sustained PS exposure enabling selective targeting.

Debate provenance: derived from debate `sess_SDA-2026-04-10-gap-debate-20260410-100359-5f096b45` on question: The debate identified a critical gap in understanding whether PS exposure is tau-specific or a general stress marker. This distinction is essential for developing selective targeting strategies and avoiding off-target effects in inflamed or stressed tissues.

Source: Debate session sess_SDA-2026-04-. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms ATP2B1, ATP2B4, Causing, Exposure, Hyperphosphorylated, Inhibits, PMCA, PMCA1. Novelty signal: skeptic-discussed-with-qualified-concession.

🧬 Mechanism

🔗 Mechanism from KG for ATP2B1 (PMCA1), ATP2B4 (PMCA4), TMEM16F, XKR4

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    Caspase_3["Caspase-3"] -->|activates| tau_cleavage["tau cleavage"]
    calcium_dysregulation["calcium dysregulation"] -->|associated with| tauopathy["tauopathy"]
    CASP3["CASP3"] -->|activates| tau_cleavage_1["tau cleavage"]
    hippocampus["hippocampus"] -->|associated with| AD_vulnerability["AD vulnerability"]
    tau_cleavage_fragments["tau cleavage fragments"] -->|associated with| NFT_bearing_neurons["NFT-bearing neurons"]
    PS_externalization["PS externalization"] -->|associated with| neuronal_loss_in_AD["neuronal loss in AD"]
    Bnip3["Bnip3"] -->|associated with| AD_brain_tissue["AD brain tissue"]
    mitochondrial_dysfunction["mitochondrial dysfunction"] -->|associated with| tauopathy_2["tauopathy"]
    hyperphosphorylated_tau["hyperphosphorylated tau"] -.->|inhibits| PMCA_pumps["PMCA pumps"]
    calcium_dysregulation_3["calcium dysregulation"] -->|activates| scramblase_activation["scramblase activation"]
    tau_N_terminal_fragments["tau N-terminal fragments"] -->|associated with| AD["AD"]
    regional_microglia_hetero["regional microglia heterogeneity"] -->|associated with| regional_vulnerability["regional vulnerability"]
    style Caspase_3 fill:#4fc3f7,stroke:#333,color:#000
    style tau_cleavage fill:#4fc3f7,stroke:#333,color:#000
    style calcium_dysregulation fill:#4fc3f7,stroke:#333,color:#000
    style tauopathy fill:#ef5350,stroke:#333,color:#000
    style CASP3 fill:#ce93d8,stroke:#333,color:#000
    style tau_cleavage_1 fill:#4fc3f7,stroke:#333,color:#000
    style hippocampus fill:#4fc3f7,stroke:#333,color:#000
    style AD_vulnerability fill:#4fc3f7,stroke:#333,color:#000
    style tau_cleavage_fragments fill:#4fc3f7,stroke:#333,color:#000
    style NFT_bearing_neurons fill:#4fc3f7,stroke:#333,color:#000
    style PS_externalization fill:#4fc3f7,stroke:#333,color:#000
    style neuronal_loss_in_AD fill:#4fc3f7,stroke:#333,color:#000
    style Bnip3 fill:#ce93d8,stroke:#333,color:#000
    style AD_brain_tissue fill:#ef5350,stroke:#333,color:#000
    style mitochondrial_dysfunction fill:#4fc3f7,stroke:#333,color:#000
    style tauopathy_2 fill:#ef5350,stroke:#333,color:#000
    style hyperphosphorylated_tau fill:#4fc3f7,stroke:#333,color:#000
    style PMCA_pumps fill:#4fc3f7,stroke:#333,color:#000
    style calcium_dysregulation_3 fill:#4fc3f7,stroke:#333,color:#000
    style scramblase_activation fill:#4fc3f7,stroke:#333,color:#000
    style tau_N_terminal_fragments fill:#4fc3f7,stroke:#333,color:#000
    style AD fill:#ef5350,stroke:#333,color:#000
    style regional_microglia_hetero fill:#4fc3f7,stroke:#333,color:#000
    style regional_vulnerability fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — ATP2B1

No curated PDB or AlphaFold mapping for ATP2B1 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for ATP2B1 (PMCA1), ATP2B4 (PMCA4), TMEM16F, XKR4 →

No DepMap CRISPR Chronos data found for ATP2B1 (PMCA1), ATP2B4 (PMCA4), TMEM16F, XKR4.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0002
Events (7d)
1
Price History
▲1.1%

💾 Resource Usage

LLM Tokens
20,994
$0.0630
Total Cost
$0.0630
Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
sourcev1_phase_c_backfill
origin_typedebate_round_mining
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.